drugset / Trial / NCT07756671

Photodynamic Therapy For Onychomycosis

NCT07756671 ↗

Phase 1 Active not recruiting 5 enrolled The University of Texas Health Science Center, Houston
NaSingle-groupOpen-labelTreatment

Summary

The purpose of this study is clinical and mycological clearance of onychomycosis using photodynamic therapy (PDT) with aminolevulinic acid (ALA) 10% gel at 6 months, 3 months, 9 months and 12 months

Timeline

Start
2026-08-10
Primary completion
2027-06-30
Completion
2027-12-31

Drugs

EvaluationDrugModalityDoseRoute
Subject Aminolevulinic Acid Diagnostic / imaging agent 10 % Topical
Background urea Unknown 20 % Topical